IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference
March 13, 2024 16:30 ET
|
iRadimed Corporation
IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference
IRADIMED CORPORATION Announces Fourth Quarter of 2023 and Full Year of 2023 Financial Results
February 08, 2024 08:05 ET
|
iRadimed Corporation
Reports record revenue of $17.5 million for the fourth quarter and $65.6 million for the full year of 2023. Reports GAAP diluted EPS of $0.36 and non-GAAP diluted EPS of $0.39 for the fourth quarter...
IRADIMED CORPORATION to Hold 2023 Fourth Quarter Financial Results Conference Call on February 8th.
February 01, 2024 16:05 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., Feb. 01, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2023 fourth quarter financial results before the market...
IRADIMED CORPORATION Reports Unaudited Fourth Quarter and 2023 Revenue
January 09, 2024 08:30 ET
|
iRadimed Corporation
Reports preliminary fourth quarter 2023 revenue of $17.5 million WINTER SPRINGS, Fla., Jan. 09, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), a leader in developing...
IRADIMED CORPORATION To Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 02, 2024 16:30 ET
|
iRadimed Corporation
IRADIMED CORPORATION Announces Participation in 42nd Annual J.P. Morgan Healthcare Conference
IRADIMED CORPORATION Announces Establishment of a Quarterly Dividend of $0.15 per share and a Special Cash Dividend of $0.48 per share
December 12, 2023 10:00 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., Dec. 12, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD) announced today that its Board of Directors approved a special cash dividend of $0.48 per...
IRADIMED CORPORATION Named a 2024 Most Successful Small-Cap Company in America by Forbes
November 30, 2023 09:00 ET
|
iRadimed Corporation
WINTER SPRING, Fla., Nov. 30, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) was recently named on Forbes’ latest list of America’s Most Successful Small-Cap...
IRADIMED CORPORATION Announces Third Quarter 2023 Financial Results
November 03, 2023 08:00 ET
|
iRadimed Corporation
Reports record revenue of $16.5 million for the third quarter of 2023.GAAP diluted EPS of $0.40 and non-GAAP diluted EPS of $0.43.Third quarter operating income of $5.9 million, an increase of 43%...
IRADIMED CORPORATION to Hold 2023 Third Quarter Financial Results Conference Call on November 3rd
October 26, 2023 16:05 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., Oct. 26, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2023 third quarter financial results before the market...
IRADIMED CORPORATION to Participate at Upcoming Investor Conferences
September 06, 2023 16:00 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., Sept. 06, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today announced that the Company will be participating in two upcoming investor...